PPARG and thyroid gland carcinoma: Treatment of thyroid cancer cells containing both RXRG and PPARγ with their ligands resulted in a synergistic increase in apoptotic activity.56 This suggests that RXRγ-PPARγ heterodimer may be present, and that the activation of this heterodimer leads to a synergistic increase in apoptosis.